Categories
FDA Issues Warning Letters to Two Chinese Firms Regarding Data Quality and Integrity Concerns, Violative Lab Practices
FDA Issues Warning Letters to Two Chinese Firms Regarding Data Quality and Integrity Concerns, Violative Lab Practices
http://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-two-chinese-firms-regarding-data-quality-and-integrity-concerns-violative
